Formulation Development White Papers & Articles

  1. 3 Key Considerations In Gene Therapy Manufacturing 7/15/2025

    Viral vector-based gene therapies are redefining medicine. As developers navigate uncharted territory, Sybil Danby of Cytiva highlights three critical areas shaping the journey from discovery to patient access.

  2. New Innovations In Monoclonal Antibody Cell Line Development 7/11/2025

    Discover how innovations in automation and digitalization are transforming CLD, streamlining biologics production, and empowering companies to overcome challenges in next-generation therapy development.

  3. 3D Biology: Accelerating Drug Discovery 7/11/2025

    The industry faces rising R&D demands as many drug candidates fail in clinical trials. Explore cost-effective technologies that improve drug screening accuracy and accelerate successful drug development.

  4. Expanding Opportunities For Inhaled Drug Delivery 7/11/2025

    Review the challenges and intricacies of effectively delivering drugs to the lung and the advantages of using nanoparticles and gentle particle processing techniques to enable delivery of sensitive drugs.

  5. Ready To Demystify Organoids? 7/1/2025

    Organoids are transforming biomedical research. Explore their top applications, research workflows, key challenges, and dissociation techniques in this comprehensive guide to personalized medicine.

  6. Efficiently Select Your Antibody Or Antibody Variant Purification Strategy 7/1/2025

    Explore the evolution of antibody therapeutics from monoclonal antibodies to next-gen formats and discover innovative strategies for purifying these complex molecules in today’s landscape.

  7. Efficiently Select And Optimize Antibody Candidates 7/1/2025

    Discover how innovative systems streamline antibody development to enhance target-binding analysis, optimize therapeutic selection, and accelerate clinical success with precision tools.

  8. Streamline Your Pathway To IND With A Rapid Tox Approach 6/26/2025

    With tox material in hand as soon as possible, antibody-derived drug developers can conduct their tox studies earlier, facilitating a timely IND submission and speeding up pathways to patients.

  9. Experimental Pain Models — SNL Model Of Neuropathic Pain 6/20/2025

    Explore how a validated Spinal Nerve Ligation (SNL) model enables effective preclinical evaluation of novel analgesics for neuropathic pain.

  10. Quicker Development Using Cell Line Integration, End-To-End Support 6/19/2025

    Despite challenges with mammalian host cell line diversity, Lonza's mitigation strategies drive efficiency and reproducibility, maximizing cell growth and product quality.